Have any questions? 706-721-6582 or cts@augusta.edu
- (Hi-Peitho) A randomized trial of ultrasound-facilitated, catheter-directed, thrombolysis versus anticoagulation for acute intermediate-high risk pulmonary embolism: The higher-risk pulmonary embolism thrombolysis study
Clinical Trial
(Hi-Peitho) A randomized trial of ultrasound-facilitated, catheter-directed, thrombolysis versus anticoagulation for acute intermediate-high risk pulmonary embolism: The higher-risk pulmonary embolism thrombolysis study
This study will compare two treatment options for patients with pulmonary embolism. Both treatments are approved to treat this condition.
- Circulatory System
- Anticoagulant
- Catheter Targeting
- Pulmonary Embolism; Thrombolysis
- Use Of Ultrasound
Eligibility Criteria
- Inclusion: 18 to 80 years of age, inclusive Confirmed diagnosis of pulmonary embolism (PE) At elevated risk of early death from PE Elevated serum troponin level Exclusion: History of stroke or at risk for catastrophic bleeding, including from anticoagulant medication Pregant or lactating Have a life expectancy of less than 6 months
RESEARCH. INNOVATION. DISCOVERY.